Related Experiment Videos
CHOP therapy: has shorter-course therapy had an impact on lymphomas?
1Division of Hematology/Oncology, Loyola University Medical Center, Maywood, Illinois 60153, USA.
Cancer Investigation
|February 25, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).
Annals of oncology : official journal of the European Society for Medical Oncology·2017
The role of body mass index in survival outcome for lymphoma patients: US intergroup experience.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2009
Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study.
Annals of oncology : official journal of the European Society for Medical Oncology·2008
Stromal gene signatures in large-B-cell lymphomas.
The New England journal of medicine·2008
The Relationship of CD4+, CD8+, and FOXP3+ Tumor-Infiltrating Lymphocytes and Their Ratios With Clinicopathological Parameters and Tumor Budding in Esophageal Squamous Cell Carcinoma.
International journal of surgical pathology·2026
Reduced Versus Full Lead-In Apixaban or Rivaroxaban in Acute Venous Thromboembolism: A Systematic Review.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Nanoparticles for fluorescence-guided breast cancer surgery: advances in in vivo preclinical research.
Nanomedicine (London, England)·2026